AAAAAA

   
Results: 1-3 |
Results: 3
ORAL ONDANSETRON-8-MG TWICE-DAILY IS AS EFFECTIVE AS 8-MG 3 TIMES DAILY IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MODERATELYEMETOGENIC CANCER-CHEMOTHERAPY
Authors: BECK TM YORK M CHANG A NAVARI R HARVEY WH MESHAD M GRIFFIN D WENTZ A
Citation: Tm. Beck et al., ORAL ONDANSETRON-8-MG TWICE-DAILY IS AS EFFECTIVE AS 8-MG 3 TIMES DAILY IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MODERATELYEMETOGENIC CANCER-CHEMOTHERAPY, Cancer investigation, 15(4), 1997, pp. 297-303
PACLITAXEL AND 5-FLUOROURACIL IN METASTATIC BREAST-CANCER - THE US EXPERIENCE
Authors: PAUL DM GARRETT AM MESHAD M DEVORE RD PORTER LL JOHNSON DH
Citation: Dm. Paul et al., PACLITAXEL AND 5-FLUOROURACIL IN METASTATIC BREAST-CANCER - THE US EXPERIENCE, Seminars in oncology, 23(1), 1996, pp. 48-52
EFFICACY OF ORAL ONDANSETRON, A SELECTIVE ANTAGONIST OF 5-HT3 RECEPTORS IN THE TREATMENT OF NAUSEA AND VOMITING ASSOCIATED WITH CYCLOPHOSPHAMIDE-BASED CHEMOTHERAPIES
Authors: CUBEDDU LX PENDERGRASS K RYAN T YORK M BURTON G MESHAD M GALVIN D CIOCIOLA AA
Citation: Lx. Cubeddu et al., EFFICACY OF ORAL ONDANSETRON, A SELECTIVE ANTAGONIST OF 5-HT3 RECEPTORS IN THE TREATMENT OF NAUSEA AND VOMITING ASSOCIATED WITH CYCLOPHOSPHAMIDE-BASED CHEMOTHERAPIES, American journal of clinical oncology, 17(2), 1994, pp. 137-146
Risultati: 1-3 |